Filing Details

Accession Number:
0000711377-20-000026
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-02 08:00:56
Reporting Period:
2020-09-30
Accepted Time:
2020-10-02 08:00:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-09-30 25,333 $40.46 67,284 No 4 M Direct
Common Stock Disposition 2020-09-30 25,333 $78.61 41,951 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2020-09-30 25,333 $0.00 25,333 $40.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
110,666 2020-09-29 2021-10-29 No 4 M Direct
Footnotes
  1. Options were granted on 9/29/2016, have five year lives, and vest 20% per year on each of the first five anniversary dates of the grant